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635Assessment of Lung Ultrasound
Artifacts (B-Lines)
Incremental Contribution to
Echocardiography in Heart Failure?
We read with a great interest the paper by Miglioranza et al. (1),
which sought to deﬁne the performance of lung ultrasound (LUS)
compared with a clinical congestion score, natriuretic peptides, and
echocardiography, to evaluate decompensation in patients with
systolic heart failure (HF) in an outpatient clinic. This paper is a
valuable effort to bridge the gap between echocardiography and
thoracic ultrasound, and their separate skills and applicationda
topic that is still quite controversial (2).
Nonetheless, we remain skeptical about the value of this test.
Four methodological observations seem relevant. First, the speci-
ﬁcity of LUS B-lines is suboptimal: in addition to pulmonary
congestion, these are visible in chronic obstructive pulmonary dis-
ease (3), pulmonary ﬁbrosis (4), and lymphangitis (2,4). Second, the
evaluation process is at best semiquantitative, because the method is
more of a subjective overview than an actual “measurement.” Third,
most reference studies have used linear or convex probes rather than
phased array transducers; the use of phased-array transducers pro-
vides a greater risk of artifacts, depending on machine settings and
particularly at lower frequencies. Finally, the actual interobserver and
intraobserver measurement range is not reported (1).
There are also some practical issues that warrant further atten-
tion. First, although the authors state that “this technique is faster to
perform, is less expensive, and has lower technical requirements
compared with a full echocardiography examination,” such a com-
parison of cost and return needs formal study. Second, the statement
“LUS could be used as an extension of the physical examination and
to differentiate hemodynamic from pulmonary congestion” warrants
examination in a mixed patient group with pulmonary disease, to
truly evaluate the ability to perform this differentiation. Third, in
our opinion, the implication of the article that pharmacological
therapy could be tailored as soon as the patient, although asymp-
tomatic, shows a signiﬁcant increase in the number of B-lines is
speculative and not yet supported by solid evidence.
In conclusion, we think that a critical reappraisal of this and other
similar papers published on B-lines is mandatory. The evaluation of
these artifacts using subjective scores is contrary to efforts to improve
the reliability and objectivity of imaging (3–5).
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B-Lines: To Count
or Not to Count?
We found the paper by Miglioranza et al. (1) interesting and useful
for routine clinical practice because their purpose is that of simpli-
fying and obtaining from an ultrasound B-line count a measure of
lung water, a “measure” of disease, that would be approachable by
all, with a short period of training. Some points, though, need to be
clariﬁed because, unfortunately, the concept of B-line is not just that.
The investigators deﬁne B-lines according to a consensus state-
ment in which only a “qualitative” description is provided without any
explanation of their origin (2), which is still debated in the literature
(3). We know from past studies that these artifacts are an expression
of an error of the ultrasound machine in interpreting acoustic in-
teractions, so we do not agree that a simple “count” of B-lines could
be an “unambiguous” measure of extravascular lung water (EVLW),
because an increase in EVLW is not the sole origin of these artifacts.
In the study (1), to rule out false positives, only patients with a prior
diagnosis of pulmonary ﬁbrosis were excluded. But B-lines are found
in many other pulmonary conditions, such as pneumonia, atelectasis,
acute lung injury/acute respiratory distress syndrome, pleural disease,
and actually any ground-glass opacity seen in CT scans. They are
a very sensitive but, unfortunately, a very nonspeciﬁc sign. Is it,
with this optic, possible to “count” an ambiguous phenomena, with
debated and artifactual origin, to deﬁne a “cutoff” parameter related to
EVLW in decompensated congestive heart failure? Other authors are
pushing in this direction, and recently, Brattain et al. (4) have tested
portable sonography with an algorithm to count and formulate a score
of EVLW.Although promising, we would like to advise practitioners
to be on guard on this subject because the risk of underestimating a
problem by simplifying it is, yes, attractive, but could have serious
clinical implications (i.e., when mechanically ventilating a patient in
the intensive care unit: the origin of disease cannot be overseen).
In the study, in all but 2 patients, lung ultrasound was performed
in the anterolateral surface of each hemithorax, following interna-
tional recommendations (2), whereas the chest x-ray was always
carried out in orthostatism. We know how water distribution in
pulmonary congestion tends to accumulate in the posteroinferior,
antigravitational regions: why not use the same position? Was there
a difference between the 2 approaches?
Moreover, the investigators use a cardiac probe (2.5 to 3.5 MHz),
although it is to date common knowledge in the ﬁeld that the
number and features of B-lines change when examined with
different probes and at different angles of assessment (5). What
would be the best probe setting to carry out a repeatable count with
the least interoperator variability?
In conclusion, the description of extension (focal/bilateral),
localization, involvement (homogeneous/dishomogeneous), and
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636gradient of distribution (gravitational/irregular) of vertical artifacts,
as well as features of the pleural line (rough/smooth/thickened),
with a standardized probe setting are pivotal in better deﬁning
B-lines, so we believe that a new approach, and not just a simple
count, should be identiﬁed in order to guide clinicians to correct
diagnosis and treatment.
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REPLY : B-Lines: a Nonspeciﬁc but Highly Informative Sign
of Pulmonary Congestion
Dr. Zanforlin, Dr. Trovato, and colleagues have raised some issues
about our study (1) that we are glad to address.
As mentioned in the paper, the lack of speciﬁcity of B-lines is well
recognized (2). Our study group was selected so that no patient had a
clinical condition apart from pulmonary congestion that was likely to
cause the detection of B-lines. Many signs that we routinely use in
clinical practice are not speciﬁc; as physicians, we should always
contextualize B-lines, as well as other biomarkers, in the overall
clinical picture. Of course, if we consider patients with other pul-
monary diseases that involve the lung interstitial space, the usefulness
of B-lines as a sign of extravascular lungwater (EVLW)decreases.We
would not advise the use of B-lines to help in differentiating hemo-
dynamic from pulmonary congestion in these subsets of patients.
We agree that evaluation of B-lines can include much more than a
simple semiquantitative estimation andwe believe that the assessment
of the pleura and subpleural features may offer important information
(2). In our study group of outpatients with heart failure and no sig-
niﬁcant pulmonary comorbidity, we considered this limited analysis to
provide an acceptable level of information. Counting B-lines is an
attempt to enrich a ﬁnding that, in our view, is not just dichotomous.
Although it is a rough semiquantiﬁcation, rather than an accurate
quantiﬁcation, it nonetheless correlates with clinical, radiological, and
invasive signs of EVLW, including gravimetric estimation (3).Moreover, B-lines have clear prognostic implications (4), even in this
speciﬁc group (5). We will be glad to utilize a more accurate way to
quantify B-lines, as soon as it becomes available.
We scanned most patients supine, limiting our evaluation to the
anterolateral chest, as in most B-line studies. Because of the short
time the patients were lying down, we believe this did not signiﬁ-
cantly change EVLW distribution from the orthostatic position. We
agree, nevertheless, that in outpatients, it is reasonable to scan the
posterior basal regions (dependent zones).
One of the advantages of evaluating B-lines is that their
assessment is not strictly dependent on 1 speciﬁc probe. The convex
or microconvex probes seem to be the most appropriate. However,
we do not believe that we should give up the meaningful infor-
mation we get in our everyday practice from lung ultrasound, just
because we do not have the perfect probe at hand. The Bland-
Altman plots showed a very low bias between probes, as well as
for interobserver and intraobserver agreement (6).
We accept the criticism that there are no data on titrating
treatments according to B-lines (2), nor studies on cost effective-
ness. In our paper, we only brieﬂy speculate about the potential
tailoring of pharmacological therapy according to B-lines, as a
possible clinical implication. A prospective, randomized trial on
dialysis patients with heart failure, comparing a standard approach
with that of B-line-driven therapy, is in progress (2).
We fully share the concern of improving the reliability and ob-
jectivity of imaging, as well as the scientiﬁc pathway to promote
them. This is why we are trying to deepen our knowledge on this
relatively new ultrasound application that, according to many au-
thors, is very promising.
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